Finding Breast Cancer–Early Detection Tools

Conservative News DailyJanuary 19, 2023

According to the National Breast Cancer FoundationIn the United States, one in eight women will develop it. breast cancer In her lifetime. Invasive breast cancer was diagnosed in 287,500 women by 2022. cancerThis year alone, 43,550 Americans will be diagnosed with breast cancer.

The screening most recommended by American doctors to detect breast carcinoma is the mammogram. However, they do. have risks. Overdiagnosis and radiation exposure are the two most dangerous. Mammograms are performed using x-rays. This is a form ionizing radiation we should avoid. Because of advances in technology, mammography has become so sensitive that it is able to pick up a wide variety of anomalies—some of which may not be cancer, some of them cancers that may not progress (such as the “stage 0” Cancer known as ductal carcinoma (in situ) and others that can regress.

In the present paradigm, once cancer is detected, it is treated with surgery, chemotherapy and radiotherapy—even without knowing if it would ever become clinically significant. This is often an overdiagnosis, which can lead to many women being exposed to significant risks from unnecessary breast cancer treatment. You can read the article: Mammograms and the associated risks. The Business of Breast Cancer: Mammogram Risks.

The good news is that there are other early detection tools that can also be helpful in identifying possible signs of breast cancer—whether those are changes in breast tissue or cancer cells in the blood. These tools can be extremely helpful in the prevention of breast cancer and they can also be very useful tools for long-term prevention strategies. Although each tool is different in terms of its scope and methods, it is important to be informed about all options for detection and prevention in order to better understand this deadly disease.

These are six early detection tools that you might not be aware of.

Thermography

Thermography as a screening tool It was introduced for the first time in 1956.

Thermography uses sensitive infrared cameras with special software to visualize and detect temperature variations in the skin. You can use it on any part of your body, but most commonly on the breasts. This allows you to detect temperature variations and heat increases.

The principle of thermography states that the metabolic activity and vascular circulation of pre-cancerous tissue is almost always greater than in normal tissue. These areas can become ‘hot spots’ This was clearly seen on a thermographic scan. ‘Hot spots’ It appears to be red in comparison to surrounding tissue which is either yellow, green, or blu.

Cancerous tumors have a voracious appetite and require an increasing supply of nutrients and blood. It can become very sick. dilates existing blood vessels, resurrects dormant vessels, and creates new vessels (neoangiogenesis), to supply blood and nutrients directly to the cancerous cells. The breast’s surface temperature rises due to increased circulation.

Unlike mammography, thermography is non-invasive—there is no radiation, no compression, the machine does not touch the body, and there is no pain. Patients are free to have as many thermography scans they like without any danger. The idea behind thermography scanners is that they are able to detect breast changes (increased warmth) years before a cancer develops.

Limitations in Thermography

Like mammography and thermography, thermography is not a diagnostic tool. It cannot determine if you have any cancer. Further testing is recommended if there is increased heat in the breast. You can use thermography to detect breast heat early and monitor changes over time.

A comprehensive review In 2020, the Journal of Medical Systems published an article that looked at various screening tools for breast cancer. The focus was on thermography. According to the review authors, thermography has been refocused by many biomedical researchers around the world due to the advancements in thermography technology and equipment. The review concluded that thermography could be used to detect breast cancer early in women, particularly younger ones.

Although Medicare does not cover the cost of a US-based thermography scan, some private insurance companies may pay a portion or all of the costs. A scan costs between $150 and $200 on average. A referral from your doctor is not required to get a scan. There are many centers offering thermography across the country.

The Oncoblot test

The ONCOblot Test was developed and created by Dr. D. James Morré and Dr. Dorothy M. Morré of Mor-NuCo, Purdue Research Park, West Lafayette, IN.

ENOX 2, a protein found in blood, can be detected using the ONCOblot test. ENOX 2, which is shed from cancer cells’ surfaces into the bloodstream, is only found in people with cancer cells. Based on over twenty years of research, the test was developed. ONCOblot labs website, can detect the presence of cancer at approximately two million cells—a very early stage.

In contrast, a mammogram can only detect a tumor made up of about 4.5 trillion cellsThe ONCOblot Test can detect breast cancer up to a decade before it is detected. mammogram You would see it. The ONCOblot is used to detect early-stage cancers before they progress.

It can also identify the tissue of origin, and thus where the primary cancer is located within the body. Knowing the cancer’s origin can help determine what treatments or lifestyle changes would be most effective for the patient moving forward.

ONCOblot Labs creators of this test claim that the Oncoblot can detect these 25 types of cancers.

• Bladder
• Breast
• Cervical
• Colorectal
• Endometrial
• Esophageal
• Gastric
• Hepatocellular
• Kidney
• Leukemia
• Non-Small cell
• Lung Small cell
• Lymphoma
• Melanoma
• Mesothelioma
• Myeloma
• Ovarian
• Pancreatic
• Prostate
• Sarcoma
• Squamous Cell
• Follicular Thyroid
• Uterine
• Papillary Thyroid
• Testicular Germ Cell

According to the ONCOblot Labs website, the ONCOblot test should be used in the following circumstances:

A patient who has had an abnormal mammogram
A suspicious PET scan
A high level of PSA Test
Once the patient has completed treatment for cancer and is being monitored for recurrence
To determine the primary form of cancer, if they have already had metastasized.

The ONCOblot labs website states they cannot accept new tests currently due to technical issues (which hopefully will be resolved soon), but there are other medical facilities and laboratories that offer the test. The Cancer Center for Healing is an integrative cancer treatment center that offers the ONCOblot test as well the RGCC test (the next one on the list), thermography scans as well the Cancer Profile and many other tests. They are located in Irvine California.

The Greece Test (RGCC).

The Greece test RGCC (Research Genetics Cancer Center), is a test that measures the number of circulating tumor cells (CTC’s) in the blood. After being released by an active tumor, circulating cancer cells are found in the bloodstream. If circulating tumor cells are released from an existing tumor, they can spread cancer to other areas of the body.

You can find an informative video that explains this process here Integrative Medicine Center of Western Colorado’s website.

This video Explains how metastasis is initiated by circulating tumor cells (single cells instead of clusters).

The following is an article published in the journal Cell Reports and conducted by the University of Basel in Switzerland, researchers found that a low-oxygen environment triggers the release of circulating tumor cells (CTC’s) from the original tumor, which are responsible for metastasis and new tumor formation elsewhere.

Dr. Ioannis Palostiriou created the RGCC test in 2004, using genetics for testing for various types of cancer. The RGCC Group claims their team of scientists has developed a range of tests that give comprehensive information about a person’s genetics, physiology, and immune profiles giving them a personalized approach to effective treatment. According to their websiteThe accuracy rate of the tests for breast, prostate and pancreas cancers is 83 to 87 per cent. A comparative study published in The Journal of Cancer Therapy in 2015 corroborates these numbers with the researchers finding that it was possible to detect CTC’s with higher sensitivity (86.2 percent) and specificity (83.9 percent) compared to standard clinical methodologies.

The RGCC Test isolates, counts, identifies. circulating tumor cells And cancer stem cells Then, they are tested against various chemotherapy agents and natural treatments. These results provide information to patients about the effectiveness of treatments against specific types of cancer and help them plan a treatment program.

The cancer stem cells are a small group of malignant cells that can produce new lines. They can self-renew, are capable of producing a lot of cells, and have an indefinite life expectancy. This could explain why cancer stem cell longevity can cause recurrences for years after treatment. They are believed to be the main driver of cancer. cancer growth and metastasis.

According to the RGCC–Research Genetics Cancer Center, if you order the test through them it is only available via their network of healthcare providers, which is accessible through their website. You can also get a consultation online.

The Cancer Profile

The Cancer Profile is used for early detection of cancer. Emil Schandl, Ph.D., was the founder of American Metabolic Laboratories, and Metabolic Research, Inc.

According to the American Metabolic Laboratories websiteCancer Profile is the test that was created by Dr. Judith A. Sullivan. It can detect cancer as early as ten to 12 years before other tests.

The Cancer Profile is comprised of seven tests.

HCG (human chorionic gonadotropin)
Both serum and urine
PHI (phosphohexose Isomerase Enzyme)
CEA (carcinoembryonic antigen)
GGTP (a liver scan)
TSH (a thyroid scan)
DHEA-S is an adrenal hormone

These tests are combined to detect early warning signs of cancer, monitor cancers already present, and see if a patient’s current treatments are working and how to adjust.

HCG, which is a hormone that is usually made during pregnancy, was one of the biomarkers. HCG can also be produced in cancerous tumors.

PHI (Phosphohexose Isomerase/Glucose Phosphate Isomerase) is another marker. PHI changes cells’ metabolism to glycolysis. This allows them to produce energy in low oxygen environments and ensures their survival. High levels of PHI create the ideal environment for cancer growth. A patient may be able to make lifestyle changes to prevent cancer if they have high levels of PHI.

Thyroid hormone function can also be measured by the Cancer Profile. Our metabolic rate is controlled by the thyroid. This is related to how much oxygen is used and available to other tissues. You are less likely to develop cancer if you have more oxygen in your cells.

A study University of Georgia discusses recent research that suggests low oxygen levels in cells could be a major cause of some cancers. According to the study, these findings do not support widely held beliefs that cancer is caused by genetic mutations.

According to the American Metabolic Laboratories website and Metabolic Research website, combined tests can detect cancer activity with an accuracy rate of 87 to 97%.

The Cancer Profile test can be purchased through the American Metabolic Laboratories or Metabolic Research website for $654. The lab will send you a kit with a tube of blood and small samples of your morning urine. Although their laboratory is located in Hollywood Florida they do accept international orders. The Cancer Center for Healing offers the Cancer Profile test.

The Gail Model – The Breast Cancer Risk Assessment Tool

Healthcare practitioners use the Breast Cancer Risk Assessment Tool to assess a woman’s risk of developing breast cancer over the next five years and within her lifetime—until the age of ninety—calculating a lifetime risk. The tool uses seven main factors to determine a woman’s risk of developing breast cancer.

Age
Age at the first period (menarche).
Age at the time of birth (or if she is not pregnant)
Breast cancer in the family (mother, sister and daughter)
Past breast biopsies
A number of breast biopsies demonstrating atypical hyperplasia
Race/ethnicity

According to the Susan G. Komen organization’s website—which claims the title of the world’s largest nonprofit of funding for the fight against breast cancer—women with a risk of 1.67 percent or higher are considered “high-risk”. 5.-year risk of 1.67% or greater FDA Guideline for taking a risk-lowering drug To reduce your risk of developing breast carcinoma in the future. Tamoxifen, Raloxifene and other risk-lowering medications are taken daily for five years as a pill. There are always risks with medications. Blood clots are possible, along with cancer, stroke and cataracts. Blood clots are the most serious side effects of Raloxifene.

The FDA approved Tamoxifen (brand-name Soltamox), in 1998 for breast cancer prevention. The FDA approved Raloxifene for breast cancer prevention 2007

Limitations on the Breast Cancer Risk Assessment Tool

There are limitations to the Breast Cancer Risk Assessment Tool. The tool can’t accurately assess the breast cancer risk of women who have the breast cancer mutation BRCA1 and BRCA2 as well as women with a history of breast cancer. in situ Breast cancer, or invasive breast carcinoma. This test does not take into account any family history of breast carcinoma beyond the first-degree relatives or any other types of cancers.

Breast Self-Examinations and Body Awareness

The best way to prevent breast cancer is to be aware of your body and do regular self-exams. There are many resources available that will help you to perform a breast self examination. You can also find many apps that will help you to navigate the process and tell you what to look out for.

One of the best ways you can ensure your health and peace of mind is to be aware of your breast shape, consistency and any changes during your cycle. If you notice any changes or feel something isn’t right, go and get it checked out by a doctor you trust.

It is important to recognize problems early in life.

Final Thoughts

These are just a few of the other tools you have to consider if you suspect you may have breast cancer. You should always do your research to determine which method is best for you. These tools can be combined to create a comprehensive preventive strategy that will allow you to stay ahead of the curve, maintain good health, and eventually, avoid cancer.

The Western model encourages us to wait until a disease has developed before we take any meaningful action. If we take a more holistic approach by living preventatively—eating well, managing stress, getting enough sleep, and balancing emotions—we are creating a healthy environment in our bodies and lives where cancer cannot thrive.

While it may not be possible to prevent cancer, you can learn about the treatment options and live naturally. This will allow your body to recover the balance it needs.

Emma Suttie is an acupuncture physician and founder of Chinese Medicine Living—a website dedicated to sharing how to use traditional wisdom to live a healthy lifestyle in the modern world. She loves the natural world, martial art, and good tea.